Kira Pharmaceuticals
PrivateLast Round
Series B
Extension
Jan 7, 2021
Total Funding Raised
$71.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Kira Pharmaceuticals is a biotechnology company that develops complement-targeted therapies to treat immune-mediated diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kira Pharmaceuticals Comparables
Compare Kira Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Apellis Pharmaceuticals | 78% | |
| Q32 Bio | 77% | |
| NovelMed Therapeutics | 77% | |
Kira Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jan 7, 2021 | ||||
| Series A | Nov 12, 2020 |
Kira Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series B Extension |
| 健壹资本 | Series A |
| Foresite Capital | Series B Extension |
| 6 Dimensions Capital | Series A |
| APlus Partners | Series B Extension |
| Qiming Venture Partners | Series B Extension, Series A |
| Vivo Capital | Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 5177% MoM, from 22 to 1.2K.
- Apr 16, 2026
Monthly visitors increased 49% MoM.
Kira Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kira Pharmaceuticals's valuation, stock price, and market status.